Simmons Bank reduced its position in MetLife, Inc. (NYSE:MET – Free Report) by 11.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,421 shares of the financial services provider’s stock after selling 432 shares during the quarter. Simmons Bank’s holdings in MetLife were worth $280,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC increased its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in shares of MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in MetLife during the third quarter worth about $30,000. Retirement Wealth Solutions LLC bought a new position in MetLife in the fourth quarter worth about $32,000. Finally, Sierra Ocean LLC acquired a new position in MetLife in the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Price Performance
Shares of MetLife stock opened at $84.08 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The company’s 50-day moving average price is $83.56 and its two-hundred day moving average price is $81.72. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The stock has a market cap of $58.22 billion, a PE ratio of 14.08, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is presently 36.52%.
Analyst Ratings Changes
MET has been the topic of a number of research reports. Wells Fargo & Company increased their price target on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Barclays lowered their price target on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Keefe, Bruyette & Woods decreased their price objective on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. Finally, BMO Capital Markets initiated coverage on MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $92.58.
View Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is a Stock Market Index and How Do You Use Them?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.